BioNTech – Medicines as Unique as You

We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.

16th August 2018

10th July 2018

29th May 2018

4th January 2018

21st December 2017

30th November 2017

BioNTech develops tailored treatments for cancer and other diseases with high unmet medical need through its world-class science and disruptive research platforms:

BioNTech’s commercial strategy is to collaborate with selected partners that have a similar drive and commitment in developing and commercializing truly innovative and disruptive immunotherapies.

BioNTech develops and commercializes a broad product pipeline using different scientific approaches and cutting-edge technology platforms. BioNTech´s clinical pipeline represents a number of industry firsts.